A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/1998
11/03/1998	US5830758 Binding to lymphocytes
11/03/1998	US5830753 Isolated nucleic acid molecules coding for tumor rejection antigen precursor dage and uses thereof.
11/03/1998	US5830717 Process for production of tricyclo compounds with streptomyces
11/03/1998	US5830671 Method for assaying for modulators of cytokines of the TFG β superfamily
11/03/1998	US5830473 Antibodies against T cells as therapeutics
11/03/1998	US5830471 Methods and compositions comprising anti-lam-1 antibodies
11/03/1998	US5830469 Novel monoclonal antibodies that specifically bind to the extracellular domain of human fas antigen (aka: apo-1) for the treatment of diseases related to excess unwanted programmed or activation-induced cell death.
11/03/1998	US5830464 Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
11/03/1998	US5830463 Yeast-based delivery vehicles
11/03/1998	US5830454 Mouse models of human disease
11/03/1998	US5830430 Cationic lipids and the use thereof
10/1998
10/30/1998	CA2231748A1 Novel g-protein coupled receptor (hfgan72x)
10/30/1998	CA2231741A1 Novel g-protein coupled receptor (hfgan72y)
10/29/1998	WO1998048022A1 HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE)
10/29/1998	WO1998048017A1 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
10/29/1998	WO1998047915A1 Neoglycoproteins
10/29/1998	WO1998047879A1 Substituted phenyl derivatives, their preparation and use
10/29/1998	WO1998047866A2 Arylsecocholadiene derivatives
10/29/1998	WO1998047529A1 Combinations of antigen and mucosal binding component for inducing specific immunological tolerance
10/29/1998	WO1998047511A1 Use of mizolastine for preparing a medicine for treating inflammation
10/29/1998	WO1998041629A3 Death domain containing receptor 5
10/29/1998	WO1998039426A3 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products
10/29/1998	WO1998030696A3 Secreted proteins and polynucleotides encoding them
10/29/1998	WO1998021233A3 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
10/29/1998	CA2287445A1 Arylsecocholadiene derivatives
10/29/1998	CA2285424A1 Substituted phenyl derivatives, their preparation and use
10/29/1998	CA2284729A1 Neoglycoproteins
10/29/1998	CA2283755A1 Human complement c3-degrading proteinase from streptococcus pneumoniae
10/28/1998	EP0874054A2 Vector for the expression of immunoglobulin-cytokine fusionproteins in malignant B Cells
10/28/1998	EP0873362A1 PROCESS FOR ISOLATING IgG AND IgA
10/28/1998	EP0873345A1 Preparation of glucosaminyl muramic acid derivatives
10/28/1998	EP0873341A1 Epothilone derivatives, preparation and use
10/28/1998	EP0873338A1 Quinoline derivatives as type iv phosphodiesterase inhibitors
10/28/1998	EP0873336A1 Antagonists of gonadotropin releasing hormone
10/28/1998	EP0873330A1 Diarylalkenylamine derivatives
10/28/1998	EP0873310A1 Diphenyl pyridyl ethane derivatives as pde iv inhibitors
10/28/1998	EP0873301A1 Indane compounds with smooth muscle relaxing and/or mast cell stabilising and/or anti-inflammatory activity
10/28/1998	EP0873295A1 Dimer-selective rxr modulators and methods for their use
10/28/1998	EP0873137A1 Compositions including calcium influx blockers for inhibiting cell growth
10/28/1998	EP0873136A2 High fluorescence specific immune enhancing factor and methods of use for same
10/28/1998	EP0873135A1 Peanut allergens and methods
10/28/1998	EP0873133A1 Biologically active composition comprising cyclosporine
10/28/1998	EP0674651B1 Substituted 6-azaandrostenones
10/28/1998	EP0649418B1 7-(2-aminoethyl)-benzothiazolones
10/28/1998	EP0407392B2 UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES
10/28/1998	CN1197450A Esters and amides as PLA2 inhibitors
10/28/1998	CN1197077A Nucleic acid construct for cell cycle regulated expression of structural genes
10/28/1998	CN1196956A Influenza vaccine
10/27/1998	US5827881 Diesters of carbonic acid endowed with antiviral and anti-inflammatory activity
10/27/1998	US5827869 Substituted biphenyl isoxazole sulfonamides
10/27/1998	US5827841 Method for enhancement of production of lymphokines and applications thereof
10/27/1998	US5827834 Method of using hyaluronic acid or its pharmaceutically acceptable salts for the treatment of disease
10/27/1998	US5827737 Stable drosophila cell line
10/27/1998	US5827708 Nucleotide sequence which codes for the polypeptide expressed by transfer ribonucleic acid synthetase gene; screening for antibacterial compounds; from genetically enginered cells
10/27/1998	CA2063721C Mycobacterium chelonae polar glycopeptidolipids-based immune booster medication
10/22/1998	WO1998046785A1 Dendritic cell hybrids
10/22/1998	WO1998046743A1 Novel ldl-receptor
10/22/1998	WO1998046645A2 Method for the production of antihuman antigen receptors and uses thereof
10/22/1998	WO1998046643A1 TUMOR NECROSIS FACTOR RECEPTOR RELATED PROTEINS TANGO-63d AND TANGO-63e
10/22/1998	WO1998046638A1 A novel th2-specific gene
10/22/1998	WO1998046633A1 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
10/22/1998	WO1998046606A1 Novel compounds
10/22/1998	WO1998046604A1 5,6,7-trisubstituted-4-aminopyridol[2,3-d]pyrimidine compounds
10/22/1998	WO1998046603A1 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
10/22/1998	WO1998046253A1 Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis
10/22/1998	WO1998046247A1 Solid phase synthesis of immunosuppressive agents
10/22/1998	WO1998046241A1 A combination therapy for hiv infections
10/22/1998	WO1998046222A1 Pharmaceutical compositions for immunosuppression, anticancer and antiviral treatment
10/22/1998	CA2287518A1 A novel th2-specific gene
10/22/1998	CA2287465A1 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
10/22/1998	CA2287085A1 Tumor necrosis factor receptor related proteins tango-63d and tango-63e
10/22/1998	CA2286791A1 Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis
10/22/1998	CA2286592A1 5,6,7-trisubstituted-4-aminopyridol[2,3-d]pyrimidine compounds
10/22/1998	CA2286478A1 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
10/22/1998	CA2286078A1 Novel compounds
10/21/1998	EP0872236A1 Eye drops
10/21/1998	EP0871756A2 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
10/21/1998	EP0871755A1 Vectors for gene delivery
10/21/1998	EP0871748A2 Delivery of biologically active polypeptides
10/21/1998	EP0871738A1 Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications
10/21/1998	EP0871672A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
10/21/1998	EP0871667A1 G-protein coupled receptor
10/21/1998	EP0871657A1 Methods for treatment and prevention of diabetes
10/21/1998	EP0871623A1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
10/21/1998	EP0871614A1 Alpha-(substituted alkylphenyl)-4-(hydroxydiphenylmethyl)-1-piperidine butanol derivatives, their preparation and their use as anti-histamines, anti-allergy agents and bronchodilators
10/21/1998	EP0871495A1 Redirection of cellular immunity by receptor chimeras
10/21/1998	EP0871490A1 Branched hydrazone linkers
10/21/1998	EP0871487A1 Dendritic cell stimulatory factor
10/21/1998	EP0871460A1 Bioactive factors of aloe vera plants
10/21/1998	EP0871456A1 Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of gvhd
10/21/1998	EP0871448A1 Aryl and heteroaryl quinazoline compounds which inhibit csf-1r receptor tyrosine kinase
10/21/1998	EP0871444A1 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use
10/21/1998	EP0871439A1 Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds
10/21/1998	EP0871436A1 USE OF Stat 6 SH2 DOMAIN SPECIFIC COMPOUNDS TO TREAT ALLERGIC REACTIONS
10/21/1998	EP0871434A1 Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases
10/21/1998	EP0710227B1 Vitamin d analogues
10/21/1998	EP0706517B1 Pyridazinone derivatives with pharmaceutical activity
10/21/1998	CN1196720A Novel vitamin D analogues
10/21/1998	CN1196678A Di-and trivalent small molecule selecting protein inhibitors
10/21/1998	CN1040327C Pyrido [2,3-d) pyrimidine-2,4-(1H, 3H)-diones and -2(1H,3H)-ones, manufacture method and use thereof

1 ... 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 ... 1172